No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US ETFDetailed Quotes
BBP Virtus Lifesci Biotech Products Etf
- 59.750
- +0.279+0.47%
Close Mar 11 15:28 ET
59.750High58.800Low
59.750High58.800Low914Volume59.062Open59.471Pre Close54.06KTurnover0.26%Turnover Ratio--P/E (Static)350.00KShares69.12052wk High--P/B20.91MFloat Cap50.43052wk Low--Dividend TTM350.00KShs Float69.120Historical High--Div YieldTTM1.60%Amplitude21.431Historical Low59.143Avg Price1Lot Size
Intraday
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Gilead Sciences Presented First Clinical Data For Its Investigational Once-Yearly Lenacapavir For HIV Prevention At CROI 2025 And Published In The Lancet
Sage Moved to Underperform at BofA; Says Biogen's Buyout Impact Has Passed
Gilead Sciences To Rally Around 11%? Here Are 10 Top Analyst Forecasts For Tuesday
The Analyst Verdict: Gilead Sciences In The Eyes Of 14 Experts
Gilead Sciences Analyst Ratings
Amgen Set for Seven Straight Sessions of Gains